Only around two percent of the human genome codes for proteins, and while those proteins carry out many important functions ...
Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...
A gene variant identified in a family and studied in a fruit fly model may offer protection against a rare X-linked seizure ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.
Scientists are unraveling the mystery of what triggers Huntington's disease, a devastating and fatal hereditary disorder that strikes in the prime of life, causing nerve cells in parts of the ...
Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...
The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions as well. But the dawn of a new way of manipulating life's building blocks ...
Based on data from the Beamion LUNG-1 trial, the FDA granted a priority review to zongertinib for patients with HER2-mutant ...
Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results